STIM
Neuronetics Inc
$3.25
0.27 (8.91%) Today
0.02 (0.72%) After-hours
— up— down
Market Cap
$243M-7.3%
Revenue (TTM)
$151.64M+69.5%
Net Income (TTM)
$-38,030,935
$-38,030,935EPS (TTM)
-0.55
-0.55Shares Out
69.59M
69.59MOpen
$3.08
$3.08Previous Close
$3.03
$3.03Day Range
$2.95 – $3.30
$2.95 – $3.3052-Week Range
$0.80 – $3.80
$0.80 – $3.80Beta
1.25
1.25Volume
1.96M
1.96MAvg Volume
2.45M
2.45MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout STIM
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Related
News
N/A
N/AN/A
BTIG Maintains Buy on Neuronetics, Raises Price Target to $6
Benzinga · 3d ago

Neuronetics, Inc. (STIM) Q2 2026 Earnings Call Transcript
SeekingAlpha · 3d ago
Neuronetics Narrows FY2026 Sales Guidance from $160.000M-$166.000M to $160.000M-$164.000M vs $161.125M Est
Benzinga · 3d ago
Neuronetics Q2 EPS $(0.05) Beats $(0.13) Estimate, Sales $41.568M Beat $40.175M Estimate
Benzinga · 3d ago